Intellia Therapeutics
Srujana B. is a highly experienced professional in quality operations and control within the pharmaceutical industry. Currently serving as a Quality Operations Lead at Intellia Therapeutics, Inc. since November 2021, Srujana is adept at managing CMO activities, coordinating testing, and ensuring compliance with GMP standards. Previously, Srujana held the position of Senior Quality Control Associate at Eurofins Lancaster Laboratories, demonstrating expertise in testing raw materials and data processing. Experience also includes roles as a Quality Assurance Analyst at Alaska Spring Pharmaceuticals and internships at Lohitha Life Sciences and Sanzyme Biologics. Srujana holds a Master’s degree in Industrial Pharmacy from Long Island University and a Bachelor’s degree in Pharmacy from Bojjam Narasimhulu Pharmacy College for Women.
This person is not in any teams
This person is not in any offices
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.